Vident Investment Advisory, LLC Affimed N.V. Transaction History

Vident Investment Advisory, LLC

  • $0
  • Q3 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$0.57 - $1.08 $29 - $56
-52 Reduced 0.3%
17,325 $10,000
Q1 2023

May 15, 2023
BUY
$0.66 - $1.29 $11,468 - $22,416
17,377 New
17,377 $13,000
Q1 2021

May 14, 2021
SELL
$5.12 - $8.48 $61,962 - $102,624
-12,102 Closed
0 $0
Q4 2020

Feb 08, 2021
SELL
$3.16 - $7.03 $11,692 - $26,011
-3,700 Reduced 23.41%
12,102 $70,000
Q3 2020

Nov 12, 2020
BUY
$3.26 - $4.73 $51,514 - $74,743
15,802 New
15,802 $54,000

Others Institutions Holding AFMD

# of Institutions
3
Shares Held
1.09M
Call Options Held
0
Put Options Held
0
View Full List

About Affimed N.V.

AFMD Quotes by TradingView
  • Ticker AFMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,339,008
  • Market Cap $520M
  • Description
  • Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...
More about AFMD
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email